Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762677
This Prospective Observational Study Aims to Evaluate the Capability of Ultra-high-resolution Photon-counting CT Angiography (UHR PCD-CTA) for Noninvasive Evaluation of Intracranial Venous Sinus Stents. The Study Will Compare Image Quality, Stent Visualization, Metal-related Artifacts, and DiagnostiXin LouRecruiting
NCT07762677Recruiting
—
This Prospective Observational Study Aims to Evaluate the Capability of Ultra-hi...Xin Lou
NCT07764003
A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Response to 2nd-generation H1-AHsHangzhou Highlightll Pharmaceutical Co., LtdNot Yet RecruitingPhase 2
NCT07764003Not Yet Recruiting
Phase 2
A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Re...Hangzhou Highlightll Phar...
NCT07762495
Echocardiographic Molecular Imaging for POC Detection of IschemiaNational Heart, Lung, and Blood Institute (NHLBI)Not Yet RecruitingEarly Phase 1
NCT07762495Not Yet Recruiting
Early Phase 1
Echocardiographic Molecular Imaging for POC Detection of IschemiaNational Heart, Lung, and...
NCT07762859
Wearable Ambulatory Vs. Office BP in HemodialysisGangnam Severance HospitalNot Yet RecruitingNot Applicable
NCT07762859Not Yet Recruiting
Not Applicable
Wearable Ambulatory Vs. Office BP in HemodialysisGangnam Severance Hospita...
NCT07761949
Assessing the Impact of Streetscape Exposure on Children's PerceptionZhongshan Ophthalmic Center, Sun Yat-sen UniversityRecruiting
NCT07761949Recruiting
—
Assessing the Impact of Streetscape Exposure on Children's PerceptionZhongshan Ophthalmic Cent...
NCT07763587
Analysis of Multimodal Psychosomatic Comorbidity Burden in Breast Cancer and Benefit Evaluation of Acupuncture Collaborative Management RegimenFirst Teaching Hospital of Tianjin University of Traditional Chinese MedicineNot Yet RecruitingNot Applicable
NCT07763587Not Yet Recruiting
Not Applicable
Analysis of Multimodal Psychosomatic Comorbidity Burden in Breast Cancer and Ben...First Teaching Hospital o...
NCT07762612
"Gwan Enjoy Life:" A Peer-Supported Mental Health Mentoring Intervention to Improve Engagement in Care Among Sexual Minority Men Living With HIV in JamaicaNational Institute of Mental Health (NIMH)Not Yet RecruitingNot Applicable
NCT07762612Not Yet Recruiting
Not Applicable
"Gwan Enjoy Life:" A Peer-Supported Mental Health Mentoring Intervention to Impr...National Institute of Men...
NCT07762482
Periodontal Tissue Stability After Surgical Correction of Altered Passive EruptionUniversity of Sao PauloRecruitingNot Applicable
NCT07762482Recruiting
Not Applicable
Periodontal Tissue Stability After Surgical Correction of Altered Passive Erupti...University of Sao Paulo
NCT07762378
Clinical Impact of a Machine Learning Decision Support System for Empirical Antibiotic TherapyInstituto de Investigación Sanitaria Gregorio MarañónNot Yet RecruitingNot Applicable
NCT07762378Not Yet Recruiting
Not Applicable
Clinical Impact of a Machine Learning Decision Support System for Empirical Anti...Instituto de Investigació...
NCT07762352
Ankle Brace vs Functional Taping In Adolescents With Chronic Ankle InstabilityEscola Superior de Saude do AlcoitaoCompletedNot Applicable
NCT07762352Completed
Not Applicable
Ankle Brace vs Functional Taping In Adolescents With Chronic Ankle InstabilityEscola Superior de Saude...
NCT07762144
Clinical Cohort Construction Program of Peking University Third HospitalPeking University Third HospitalEnrolling By Invitation
NCT07762144Enrolling By Invitation
—
Clinical Cohort Construction Program of Peking University Third HospitalPeking University Third H...
NCT07764198
A Randomized Controlled Trial of Gabor-Based Perceptual Learning for Adult AmblyopiaJiannan HuangRecruitingNot Applicable
NCT07764198Recruiting
Not Applicable
A Randomized Controlled Trial of Gabor-Based Perceptual Learning for Adult Ambly...Jiannan Huang
NCT07762313
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular Conduit in Adolescents With Extremity Arterial Injury.Humacyte, Inc.Not Yet RecruitingPhase 3
NCT07762313Not Yet Recruiting
Phase 3
An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular...Humacyte, Inc.
NCT07763964
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fed Study.ADIUMCompletedNot Applicable
NCT07763964Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07762430
Food Noise Survey Development and Validation in Hindi and English-Speaking AdultsDiabetes Foundation, IndiaNot Yet Recruiting
NCT07762430Not Yet Recruiting
—
Food Noise Survey Development and Validation in Hindi and English-Speaking Adult...Diabetes Foundation, Indi...
NCT07763808
Surgical Treatment for Gingival Recessions After Orthodontic TreatmentAziz Aliyev Azerbaijan State Advanced Training Institute for DoctorsRecruitingPhase 2
NCT07763808Recruiting
Phase 2
Surgical Treatment for Gingival Recessions After Orthodontic TreatmentAziz Aliyev Azerbaijan St...
NCT07762274
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke and Brain Injury, Further Validation of RehAtt® DiSTRO Assessment of Cognitive and Visual FunctionDepartment of clinical sciences at Danderyd hospitalCompleted
NCT07762274Completed
—
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke an...Department of clinical sc...
NCT07763171
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal AdenocarcinomaGruppo Oncologico del Nord-OvestNot Yet RecruitingPhase 3
NCT07763171Not Yet Recruiting
Phase 3
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-neg...Gruppo Oncologico del Nor...
Result Breakdown
Not yet recruiting10 (50%)
Recruiting6 (30%)
Completed3 (15%)
Enrolling by invitation1 (5%)
not_applicable8 (40%)
Not Specified7 (35%)
Phase 22 (10%)
Phase 32 (10%)
Early Phase 11 (5%)